Clinical Trial Update: Feasibility of Providing Cognitive Remediation to People With Schizophrenia in a Clinical Network [Phase 4]

View source ↗

Summary

Phase 4 feasibility trial completed to assess providing cognitive remediation to people with schizophrenia within a clinical network.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED